Cite
HARVARD Citation
Borin, M. et al. (2020). Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study. Clinical pharmacology in drug development. 9 (1), pp. 130-139. [Online].